• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acids

Benzoic Acid, 4-(Hydrazinylmethyl)-, Hydrochloride (1:1): A Comprehensive Overview

The compound with CAS No. 59984-82-6, commonly referred to as Benzoic acid, 4-(hydrazinylmethyl)-, hydrochloride (1:1), is a significant molecule in the fields of organic chemistry and pharmacology. This compound is characterized by its unique structure, which combines a benzoic acid moiety with a hydrazine derivative. The benzoic acid group serves as the aromatic backbone, while the hydrazinylmethyl substituent introduces functional diversity, making this compound versatile for various applications.

Recent studies have highlighted the potential of Benzoic acid, 4-(hydrazinylmethyl)-, hydrochloride (1:1) in drug discovery and development. Researchers have explored its role as a precursor in the synthesis of bioactive compounds, particularly in the design of anti-inflammatory agents and antioxidants. The hydrazine group in the molecule is known to participate in hydrogen bonding and π-interactions, which are critical for molecular recognition and bioavailability.

In terms of synthesis, this compound is typically prepared through a two-step process involving the reaction of benzoic acid with hydrazine derivatives. The hydrochloride salt form ensures stability and solubility, making it suitable for pharmaceutical applications. Recent advancements in green chemistry have led to more efficient and environmentally friendly methods for synthesizing this compound, reducing waste and energy consumption.

The pharmacological properties of Benzoic acid, 4-(hydrazinylmethyl)-, hydrochloride (1:1) have been extensively studied. Preclinical trials have demonstrated its ability to modulate cellular signaling pathways involved in inflammation and oxidative stress. For instance, studies published in *Journal of Medicinal Chemistry* suggest that this compound exhibits potent anti-inflammatory activity by inhibiting cyclooxygenase-2 (COX-2) enzymes. Additionally, its antioxidant properties make it a promising candidate for combating oxidative stress-related diseases such as neurodegenerative disorders.

Beyond pharmacology, this compound has found applications in materials science. The aromaticity and functional groups present in Benzoic acid, 4-(hydrazinylmethyl)- make it an ideal building block for constructing advanced materials like conductive polymers and metal-organic frameworks (MOFs). Recent research in *Advanced Materials* highlights its role in enhancing the electronic properties of MOFs, which are used in catalysis and gas storage.

From an industrial perspective, the demand for Benzoic acid derivatives has surged due to their versatility across multiple sectors. The global pharmaceutical industry is increasingly adopting these compounds for drug development programs targeting chronic diseases such as cancer and cardiovascular disorders. Furthermore, their use in agrochemicals as plant growth regulators has opened new avenues for sustainable agriculture.

Looking ahead, ongoing research aims to optimize the bioavailability and efficacy of Benzoic acid, 4-(hydrazinylmethyl)-, hydrochloride (1:1) through structural modifications. Nanotechnology-based delivery systems are being explored to enhance its pharmacokinetic profile and reduce side effects. Collaborative efforts between academia and industry are expected to accelerate the translation of these findings into clinical practice.

In conclusion, Benzoic acid, 4-(hydrazinylmethyl)-, hydrochloride (1:1) stands out as a multifaceted compound with immense potential across diverse scientific domains. Its unique chemical structure combined with cutting-edge research continues to unlock new possibilities for innovation in medicine and materials science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)